![Susan M. Flint](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Susan M. Flint
Nessuna posizione attualmente
Storia della carriera di Susan M. Flint
Precedenti posizioni note di Susan M. Flint
Società | Posizione | Inizio | Fine |
---|---|---|---|
WILSON THERAPEUTICS AB | Direttore operativo | 01/09/2014 | 01/03/2019 |
PRESSURE BIOSCIENCES, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/1995 | 01/01/1997 |
NAVIDEA BIOPHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | - | - |
Oxyrane, Ltd. | Direttore/Membro del Consiglio | - | - |
Direttore Tecnico/Scientifico/R&S | - | - | |
Oxyrane UK Ltd.
![]() Oxyrane UK Ltd. Pharmaceuticals: MajorHealth Technology Oxyrane UK Ltd. engages in the development of novel enzyme replacement therapies for lysosomal storage disorders. Its product is a pre-clinical ERT for Pompe Disease - a serious muscle disease - produced using engineered yeast cells. The firm develops recombinant enzyme products using a proprietary, engineered yeast expression platform based on Yarrowia lipolytica. The company was founded by Robin Kumar Mitra, Adriana L. Botes and Michael Campbell in 2006 and is headquartered in Manchester, the United Kingdom. | Direttore/Membro del Consiglio | 14/01/2013 | - |
Corporate Officer/Principal | 14/01/2013 | - | |
EPIX Pharmaceuticals, Inc.
![]() EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Direttore operativo | - | - |
Consigliere Generale | - | - | |
Cato Research LLC
![]() Cato Research LLC Miscellaneous Commercial ServicesCommercial Services Cato Research LLC operates as an international regulatory and clinical contract research organization. It offers clinical strategy, clinical trial services, data management and biostatistics, medical and pharmacovigilance, medical writing, pharmacokinetics, preclinical/nonclinical services, project management, quality assurance, and regulatory affairs. The company was founded by Allen Cato and Lynda Sutton in 1988 and is headquartered in Durham, NC. | Corporate Officer/Principal | - | - |
ALSERES PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 11/01/2010 | 22/07/2011 |
Corporate Officer/Principal | 01/06/2007 | 11/01/2010 |
Formazione di Susan M. Flint
Northeastern University | Graduate Degree |
Bridgewater State College | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 8 |
Regno Unito | 2 |
Svezia | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 4 |
Corporate Officer/Principal | 3 |
Chief Operating Officer | 2 |
Settori
Health Technology | 7 |
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
ALSERES PHARMACEUTICALS, INC. | Health Technology |
PRESSURE BIOSCIENCES, INC. | Health Technology |
NAVIDEA BIOPHARMACEUTICALS, INC. | Health Technology |
Aziende private | 5 |
---|---|
Cato Research LLC
![]() Cato Research LLC Miscellaneous Commercial ServicesCommercial Services Cato Research LLC operates as an international regulatory and clinical contract research organization. It offers clinical strategy, clinical trial services, data management and biostatistics, medical and pharmacovigilance, medical writing, pharmacokinetics, preclinical/nonclinical services, project management, quality assurance, and regulatory affairs. The company was founded by Allen Cato and Lynda Sutton in 1988 and is headquartered in Durham, NC. | Commercial Services |
EPIX Pharmaceuticals, Inc.
![]() EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Health Technology |
Oxyrane UK Ltd.
![]() Oxyrane UK Ltd. Pharmaceuticals: MajorHealth Technology Oxyrane UK Ltd. engages in the development of novel enzyme replacement therapies for lysosomal storage disorders. Its product is a pre-clinical ERT for Pompe Disease - a serious muscle disease - produced using engineered yeast cells. The firm develops recombinant enzyme products using a proprietary, engineered yeast expression platform based on Yarrowia lipolytica. The company was founded by Robin Kumar Mitra, Adriana L. Botes and Michael Campbell in 2006 and is headquartered in Manchester, the United Kingdom. | Health Technology |
Wilson Therapeutics AB
![]() Wilson Therapeutics AB Pharmaceuticals: MajorHealth Technology Wilson Therapeutics AB engages in the development of novel therapies for patients with rare copper-mediated disorders. The company was founded on April 25, 2012 and is headquartered in Stockholm, Sweden. | Health Technology |
Oxyrane, Ltd. |
- Borsa valori
- Insiders
- Susan M. Flint
- Esperienza